Advertisement
Screener

Enovis Corp (ENOV) Gain (Loss) Related to Litigation Settlement

2.1 / 5 stars · 44/106 Roast Me

Enovis Corp Gain (Loss) Related to Litigation Settlement

Enovis Corp (ENOV) reported Gain (Loss) Related to Litigation Settlement of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.

Financial Statements › Income Statement › Other Income

us-gaap:GainLossRelatedToLitigationSettlement · last filed 2025-02-26

  • Enovis Corp gain (loss) related to litigation settlement for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
  • Enovis Corp gain (loss) related to litigation settlement for the quarter ending 2023-09-29 was $0.00.
  • Enovis Corp gain (loss) related to litigation settlement for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
  • Enovis Corp gain (loss) related to litigation settlement for the quarter ending 2022-12-31 was $4.60M.
  • Enovis Corp gain (loss) related to litigation settlement for fiscal 2024 was $0.00.
  • Enovis Corp gain (loss) related to litigation settlement for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • Enovis Corp gain (loss) related to litigation settlement for fiscal 2022 was $36.70M.
  • Enovis Corp gain (loss) related to litigation settlement for fiscal 2021 was $0.00.
Period endGain (Loss) Related to Litigation Settlement 3 monthGain (Loss) Related to Litigation Settlement 6 monthGain (Loss) Related to Litigation Settlement 9 monthGain (Loss) Related to Litigation Settlement 12 month
2024-12-31$0.00
10-K · filed 2025-02-26
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$0.00
derived: sum of 2 quarters · filed 2025-02-26
$0.00
derived: sum of 3 quarters · filed 2025-02-26
$0.00
10-K · filed 2025-02-26
2023-09-29$0.00
10-Q · filed 2023-11-07
$0.00
derived: sum of 2 quarters · filed 2023-11-07
$0.00
10-Q · filed 2023-11-07
2023-06-30$0.00
10-Q · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
2022-12-31$4.60M
10-K · filed 2023-03-01
$3.63M
derived: sum of 2 quarters · filed 2023-11-07
$36.66M
derived: sum of 3 quarters · filed 2023-11-07
$36.70M
10-K · filed 2025-02-26
2022-09-30-$975.00K
10-Q · filed 2023-11-07
$32.06M
derived: sum of 2 quarters · filed 2023-11-07
$32.06M
10-Q · filed 2023-11-07
2022-07-01$33.03M
10-Q · filed 2023-08-03
$33.03M
10-Q · filed 2023-08-03
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$0.00
derived: sum of 2 quarters · filed 2024-02-22
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$0.00
10-K · filed 2024-02-22
2021-10-01$0.00
10-Q · filed 2022-11-02
$0.00
derived: sum of 2 quarters · filed 2022-11-02
$0.00
10-Q · filed 2022-11-02
2021-07-02$0.00
10-Q · filed 2022-08-04
$0.00
10-Q · filed 2022-08-04
2020-12-31$0.00
10-K · filed 2023-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85